Valentina V. Simonova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Valentina V. Simonova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail A. Guzeev
Russian Academy of Sciences
6 shared publications - Irina V. Ekimova
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia
5 shared publications - Yuri F. Pastukhov
Russian Academy of Sciences
5 shared publications M. V. Chernyshev
Russian Academy of Sciences
3 shared publications- Darya A. Meshalkina
Interdisciplinary Laboratory of Neurobiology, Sechenov Institute of Evolutional Physiology and Biochemistry, 194223 St. Petersburg, Russia
1 shared publication I. V. Guzhova
Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 18 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4464
Chaperone Hsp70 (HSPA1) Is Involved in the Molecular Mechanisms of Sleep Cycle Integration
The molecular mechanisms of sleep cycle integration at the beginning and the end of the inactive period are not clear. Sleep cycles with a predominance of deep slow-wave sleep (SWS) seem to be associated with accelerated protein synthesis in the brain. The inducible Hsp70 chaperone corrects protein conformational changes and has protective properties. This research explores (1) whether the Hspa1 gene encoding Hsp70 protein activates during the daily rapid-eye-movement sleep (REMS) maximum, and (2) whether a lower daily deep SWS maximum affects the Hspa1 expression level during the subsequent REMS. Combining polysomnography in male Wistar rats, RT-qPCR, and Western blotting, we reveal a three-fold Hspa1 upregulation in the nucleus reticularis pontis oralis, which regulates REMS. Hspa1 expression increases during the daily REMS maximum, 5–7 h after the natural peak of deep SWS. Using short-term selective REMS deprivation, we demonstrate that REMS rebound after deprivation exceeds the natural daily maximum, but it is not accompanied by Hspa1 upregulation. The results suggest that a high proportion of deep SWS, usually observed after sleep onset, is a necessary condition for Hspa1 upregulation during subsequent REMS. The data obtained can inform the understanding of the molecular mechanisms integrating SWS and REMS and key biological function(s) of sleep.
- 18 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4464
Open AccessChaperone Hsp70 (HSPA1) Is Involved in the Molecular Mechanisms of Sleep Cycle Integration
The molecular mechanisms of sleep cycle integration at the beginning and the end of the inactive period are not clear. Sleep cycles with a predominance of deep slow-wave sleep (SWS) seem to be associated with accelerated protein synthesis in the brain. The inducible Hsp70 chaperone corrects protein conformational changes and has protective properties. This research explores (1) whether the Hspa1 gene encoding Hsp70 protein activates during the daily rapid-eye-movement sleep (REMS) maximum, and (2) whether a lower daily deep SWS maximum affects the Hspa1 expression level during the subsequent REMS. Combining polysomnography in male Wistar rats, RT-qPCR, and Western blotting, we reveal a three-fold Hspa1 upregulation in the nucleus reticularis pontis oralis, which regulates REMS. Hspa1 expression increases during the daily REMS maximum, 5–7 h after the natural peak of deep SWS. Using short-term selective REMS deprivation, we demonstrate that REMS rebound after deprivation exceeds the natural daily maximum, but it is not accompanied by Hspa1 upregulation. The results suggest that a high proportion of deep SWS, usually observed after sleep onset, is a necessary condition for Hspa1 upregulation during subsequent REMS. The data obtained can inform the understanding of the molecular mechanisms integrating SWS and REMS and key biological function(s) of sleep.
- 12 June 2019
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 49 (5) , 580-583
Slow-Wave Sleep and Anxiety Levels in Rats in Chronic Deficiency of Chaperone Hsp70i in the Preoptic Area of the Hypothalamus
- 12 June 2019
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 49 (5) , 580-583
Slow-Wave Sleep and Anxiety Levels in Rats in Chronic Deficiency of Chaperone Hsp70i in the Preoptic Area of the Hypothalamus
- Open Access
- 1 January 2018
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 118 (4) , 14-20
Changes in characteristics of sleep-wake cycle and motor activity at the preclinical stage of Parkinson's disease in old rats
Medical article медицинская статья
- 1 January 2018
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 118 (4) , 14-20
Open AccessChanges in characteristics of sleep-wake cycle and motor activity at the preclinical stage of Parkinson's disease in old rats
Medical article медицинская статья
- 1 September 2017
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 53 (5) , 431-434
Signs of sleep and behavior disorders indicating the initial stage of neurodegeneration in a rat model of Parkinson’s disease
- 1 September 2017
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 53 (5) , 431-434
Signs of sleep and behavior disorders indicating the initial stage of neurodegeneration in a rat model of Parkinson’s disease
- 1 November 2016
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 52 (6) , 463-474
Changes in sleep characteristics of rat preclinical model of Parkinson’s disease based on attenuation of the ubiquitin—proteasome system activity in the brain
Numerous experimental and epidemiological data indicate a high significance of environmental neurotoxins, specifically, inhibitors of the ubiquitin–proteasome system, in pathogenesis of Parkinson’s disease (PD). To develop a preclinical model of PD in rats we used a technique of intranasal administration of lactacystin, a natural proteasome inhibitor, into the brain. It was found that three weeks after the first lactacystin administration it induced a little degeneration of dopaminergic neurons in the olfactory bulb and substantia nigra pars compacta without any olfactory dysfunction and motor behavior disorders. Besides, its effect led to the appearance of some signs of sleep disorders: increased somnolence (especially in the dark, active daily phase), fragmentation of slow-wave sleep, decreased EEG delta rhythm during slow-wave sleep. These signs share some similarity with PD and could be useful in clinical studies for the quick search for polysomnographic markers of the early PD stage.
- 1 November 2016
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 52 (6) , 463-474
Changes in sleep characteristics of rat preclinical model of Parkinson’s disease based on attenuation of the ubiquitin—proteasome system activity in the brain
Numerous experimental and epidemiological data indicate a high significance of environmental neurotoxins, specifically, inhibitors of the ubiquitin–proteasome system, in pathogenesis of Parkinson’s disease (PD). To develop a preclinical model of PD in rats we used a technique of intranasal administration of lactacystin, a natural proteasome inhibitor, into the brain. It was found that three weeks after the first lactacystin administration it induced a little degeneration of dopaminergic neurons in the olfactory bulb and substantia nigra pars compacta without any olfactory dysfunction and motor behavior disorders. Besides, its effect led to the appearance of some signs of sleep disorders: increased somnolence (especially in the dark, active daily phase), fragmentation of slow-wave sleep, decreased EEG delta rhythm during slow-wave sleep. These signs share some similarity with PD and could be useful in clinical studies for the quick search for polysomnographic markers of the early PD stage.
- 1 March 2015
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 461 (1) , 76-79
Chaperone Hsp70 is involved in the molecular mechanisms of slow wave sleep regulation
- 1 March 2015
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 461 (1) , 76-79
Chaperone Hsp70 is involved in the molecular mechanisms of slow wave sleep regulation